| 前收市價 | 1.1300 |
| 開市 | 0.6300 |
| 買盤 | 0.0000 |
| 賣出價 | 0.5000 |
| 拍板 | 50.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.6300 - 1.1300 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 66 |
ZacksEli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
ZacksAmgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Amgen's (AMGN) Imdelltra is the first DLL3-targeting BiTE therapy that activates the patient's own T cells to attack DLL3-expressing tumor cells.
ZacksIonis (IONS), Biogen Down on Ending Development of ALS Drug
Ionis (IONS) and Biogen (BIIB) stop developing their experimental ALS drug after a phase I/II study failed to show improvement in patients.
